All articles tagged with #richard pazdur
Richard Pazdur, the top FDA drug regulator, plans to retire just weeks after starting the job, amid concerns over the agency's legal and procedural approaches to drug approvals, contributing to recent instability at the FDA.
Richard Pazdur, the top drug regulator at the FDA, resigned just three weeks after taking the role amid disagreements over agency overhaul plans and concerns about transparency and legality, highlighting ongoing turmoil within the agency.
Richard Pazdur, the top drug regulator at the FDA, has announced his retirement at the end of the month, adding to concerns about leadership instability at the agency amid recent turnover.
The FDA has appointed oncology expert Richard Pazdur as the new head of the Center for Drug Evaluation and Research, succeeding George Tidmarsh amid a period of leadership turmoil.
The FDA is facing challenges in appointing a new head of its drug center following the abrupt departure of George Tidmarsh, with potential candidates like Richard Pazdur and Mary Thanh Hai declining the role, prompting the agency to open the position to internal staff.